Early Detection: Screening for Breast Cancer

Implementation for screening for breast cancer requires several steps:

The natural history of breast cancer is long. The disease process begins about age 25, and in situ cancer appears between the ages of 40 to 50. Screening in this age group with mammography remains controversial. Small invasive cancers begin about age 50 through age 60, when large invasive cancers are seen leading to death about age 65. Currently clinical trials show that population screening has maximum cost-effectiveness in this 50-60 through 69 year age group.

Process, impact and outcome measures are used to monitor and evaluate secondary prevention programs. For breast cancer screening, examples might include (WHO,1995):

Process Measures
More than 80% of women aged 40 and over are educated about breast cancer screening.
More than 80% of primary health workers are educated and trained in breast examination and teaching BSE, and about screening policies.

Impact Measures:
Over 80% of women in the target 40 or older age group are examined at least once, and taught BSE.
Over 70% of women aged 50-69 are screened using mammography.

Outcome Measures
Short Term: More than one-third of breast cancers are discovered by screening. In mammography programs, the ration of cancers detected at first screen is three times the expected incidence.
Medium Term There is a more than 15% reduction in cases presenting with advanced disease (stage II and beyond).
Long Term: There is more than 15% reduction in the mortality of breast cancer.

Click to return to slide 19